서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2019-02	Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial Herbst, R. S.; Baas, P.; Perez-Gracia, J. L.; Felip, E.; Kim, D. -W.; Han, J. -Y.; Molina, J. R.; Kim, J. -H.; Arvis, C. Dubos; Ahn, M. -J.; Majem, M.; Fidler, M. J.; Surmont, V.; de Castro, G., Jr.; Garrido, M.; Shentu, Y.; Emancipator, K.; Samkari, A.; Jensen, E. H.; Lubiniecki, G. M.; Garon, E. B. Annals of Oncology, Vol.30 No.2, pp.281-289	DOI
2019-03	KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Ohtsu, Atsushi; Tabernero, Josep; Ilson, David H.; Hyung, Woo Jin; Strong, Vivian E.; Goetze, Thorsten Oliver; Yoshikawa, Takaki; Tang, Laura H.; Hwang, Peggy May Tan; Webb, Nancy; Adelberg, David; Shitara, Kohei Future Oncology, Vol.15 No.9, pp.943-952	DOI
2020-05	Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study Schmid, P.; Salgado, R.; Park, Y. H.; Munoz-Couselo, E.; Kim, S. B.; Sohn, J.; Im, S. -A.; Foukakis, T.; Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.; Cortes, J.; Loi, S. Annals of Oncology, Vol.31 No.5, pp.569-581	DOI
2021-02	First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 Chung, Hyun Cheol; Bang, Yung-Jue; S Fuchs, Charles; Qin, Shu-Kui; Satoh, Taroh; Shitara, Kohei; Tabernero, Josep; van Cutsem, Eric; Alsina, Maria; Cao, Zhu Alexander; Lu, Jia; Bhagia, Pooja; Shih, Chie-Schin; Janjigian, Yelena Y. Future Oncology, Vol.17 No.5, pp.491-501	DOI
2021-03	Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer Perets, R.; Bar, J.; Rasco, D. W.; Ahn, M-J; Yoh, K.; Kim, D-W; Nagrial, A.; Satouchi, M.; Lee, D. H.; Spigel, D. R.; Kotasek, D.; Gutierrez, M.; Niu, J.; Siddiqi, S.; Li, X.; Cyrus, J.; Chackerian, A.; Chain, A.; Altura, R. A.; Cho, B. C. Annals of Oncology, Vol.32 No.3, pp.395-403
2021-03	KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma Tabernero, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Janjigian, Yelena Yuriy; Bhagia, Pooja; Li, Kan; Adelberg, David; Qin, Shu Kui Future Oncology, Vol.17 No.22, pp.2847-2855	DOI
2021-08	Quality of life with first-line pembrolizumab for PD-L1epositive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study Van Cutsem, E.; Valderrama, A.; Bang, Y. -J.; Fuchs, C. S.; Shitara, K.; Janjigian, Y. Y.; Qin, S.; Larson, T. G.; Shankaran, V.; Stein, S.; Norquist, J. M.; Kher, U.; Shah, S.; Alsina, M. Esmo Open, Vol.6 No.4, p. 100189	DOI
2021-09	Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma Shitara, K.; Ozguroglu, M.; Bang, Y-J; Di Bartolomeo, M.; Mandala, M.; Ryu, M-H; Caglevic, C.; Chung, H. C.; Muro, K.; Van Cutsem, E.; Kobie, J.; Cristescu, R.; Aurora-Garg, D.; Lu, J.; Shih, C-S; Adelberg, D.; Cao, Z. A.; Fuchs, C. S. Annals of Oncology, Vol.32 No.9, pp.1127-1136	DOI
2022-02	First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer Niu, J.; Maurice-Dror, C.; Lee, D. H.; Kim, D. -W.; Nagrial, A.; Voskoboynik, M.; Chung, H. C.; Mileham, K.; Vaishampayan, U.; Rasco, D.; Golan, T.; Bauer, T. M.; Jimeno, A.; Chung, V.; Chartash, E.; Lala, M.; Chen, Q.; Healy, J. A.; Ahn, M. -J. Annals of Oncology, Vol.33 No.2, pp.169-180	DOI

1